Pretell 2000.

Methods	Controlled clinical trial Duration: dates not stated, 3 months follow up
Participants	Number: 26 (16 males, 10 females) Inclusion criteria: single enhancing lesion in the brain parenchyma Exclusion criteria: pregnancy, other intracranial pathology
Interventions	Group 1: Praziquantel 3 doses (25 mg/ kg) at 2‐hour intervals for 1 day Group 2: No antiparasitic therapy
Outcomes	Adverse effects of treatment, radiological resolution of lesions
Notes	Location: Peru Source of funding: the Food and Drug Administration; the Fogarty Foundation/NIH; NIAID/NIH (USA)